News
Your blood sugar can affect more than your propensity for diabetes. In fact, high blood sugar may be causing you to lose out ...
In this population-based cohort study, patients with type 2 diabetes who received glucagon-like peptide-1 receptor agonists had a higher risk of developing gastroesophageal reflux disease and ...
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, ...
GLP-1s drive a historic shift in traditional drug spending increases, outpacing specialty drug trends for the first time.
Individuals with type 2 diabetes who receive treatment with GLP-1 RAs do not have an increased risk for acute pancreatitis.
While severe climate-related disasters were linked with decreased access to health care infrastructure, moderate climate-related disasters were linked with increased access and redevelopment. In other ...
A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side effect of weight loss drugs.
SAN FRANCISCO -- In order to maximize weight loss, a GLP-1 receptor agonist may be needed both before and after bariatric ...
GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Regarding injection site rotation, alternate between different areas like the abdomen, thigh, or upper arm to prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results